Variable | N | Physical symptoms | Â | Mental status | Â | Illness perception | Â | Family relationship | Â | Treatment dimension | Â |
---|---|---|---|---|---|---|---|---|---|---|---|
 |  | Mean (SD) | F | Mean (SD) | F | Mean (SD) | F | Mean (SD) | F | Mean (SD) | F |
Gender | Â | Â | 4.73* | Â | 4.50* | Â | 0.15 | Â | 0.18 | Â | 0.03 |
Male | 400 | 64.44 (24.38) | Â | 66.18 (25.98) | Â | 54.08 (27.74) | Â | 59.33 (27.10) | Â | 62.41 (22.73) | Â |
Female | 83 | 58.07 (23.85) | Â | 59.48 (27.05) | Â | 52.76 (29.82) | Â | 60.71 (25.95) | Â | 61.96 (20.66) | Â |
Household monthly income per capita (Yuan) | Â | Â | 16.37***a | Â | 7.30** | Â | 1.18 | Â | 2.57 | Â | 9.98*** |
< 600 I | 34 | 46.81 (22.34) |  | 52.94 (23.64) |  | 47.18 (26.59) |  | 52.12 (21.80) |  | 51.68 (24.17) |  |
600 ~ 6000 II | 349 | 62.74 (24.78) |  | 64.25 (26.37) |  | 53.98 (28.42) |  | 59.11 (27.35) |  | 61.27 (22.07) |  |
> 6000 III | 100 | 71.06 (20.36) |  | 71.83 (25.05) |  | 55.71 (27.27) |  | 63.72 (26.34) |  | 69.67 (20.81) |  |
post-hoc | Â | I<II<III b | Â | I<III, II<III c | Â | NS c | Â | NS c | Â | I<III, II<III c | Â |
Plasma HIV-1 RNA level (copies/ml) |  |  | 0.02 |  | 0.14 |  | 0.27 |  | 2.91 |  | < 0.01 |
< 20 | 189 | 58.50 (24.57) |  | 59.45 (24.90) |  | 54.12 (24.75) |  | 55.35 (26.39) |  | 57.43 (22.74) |  |
≥ 20 | 23 | 57.49 (30.55) |  | 57.39 (26.95) |  | 51.27 (24.21) |  | 65.22 (24.34) |  | 57.66 (21.90) |  |
CD4+T cell count (cell/µl) |  |  | 14.86*** a |  | 8.20*** |  | 5.03** a |  | 3.91* |  | 20.07*** a |
< 200 I | 77 | 49.75 (28.77) |  | 57.97 (25.50) |  | 44.10 (30.40) |  | 53.61 (28.99) |  | 48.92 (25.23) |  |
200 ~ 500 II | 238 | 63.67 (23.83) |  | 63.28 (25.65) |  | 56.32 (25.87) |  | 59.20 (26.57) |  | 62.42 (21.51) |  |
> 500 III | 112 | 70.01 (19.14) |  | 72.29 (24.06) |  | 54.54 (27.88) |  | 64.48 (24.28) |  | 69.88 (18.06) |  |
post-hoc | Â | I<II<III b | Â | I<III, II<III c | Â | I<II, I<III b | Â | I<III c | Â | I<II<III b | Â |
HIV serostatus | Â | Â | 3.02 a | Â | 0.11 | Â | 3.59* a | Â | 0.29 | Â | 5.62** a |
HIV positive-asymptomaticI | 282 | 65.09 (22.21) | Â | 65.08 (26.20) | Â | 56.65 (26.18) | Â | 60.32 (25.84) | Â | 65.32 (19.04) | Â |
HIV positive-symptomaticII | 85 | 64.90 (24.71) | Â | 65.96 (27.23) | Â | 52.01 (30.51) | Â | 59.02 (28.65) | Â | 59.10 (25.65) | Â |
AIDSIII | 116 | 57.95 (28.32) | Â | 64.20 (25.90) | Â | 48.42 (29.98) | Â | 58.14 (28.18) | Â | 57.45 (26.04) | Â |
post-hoc | Â | NS b | Â | NS c | Â | III<I b | Â | NS c | Â | III<I b | Â |
Comorbidity | Â | Â | 8.64** a | Â | 2.23 | Â | 1.29 | Â | 1.1 | Â | 3.46 |
No | 337 | 65.69(21.99) | Â | 66.26(25.05) | Â | 54.81(27.19) | Â | 60.40(26.20) | Â | 63.69(20.57) | Â |
Yes | 146 | 57.91(28.51) | Â | 62.17(28.75) | Â | 51.66(30.02) | Â | 57.65(28.40) | Â | 59.20(25.87) | Â |
Liver function |  |  | 0.11 |  | 0.55 |  | 1.65 |  | 2.23 |  | < 0.01 |
Normal | 126 | 63.07(24.32) | Â | 67.25(25.42) | Â | 50.96(28.74) | Â | 56.57(25.73) | Â | 62.83(20.83) | Â |
Abnormal | 334 | 63.90(24.34) | Â | 65.22(26.49) | Â | 54.74(28.00) | Â | 60.78(27.37) | Â | 62.88(22.79) | Â |
Kidney function | Â | Â | 0.05 | Â | 0.05 | Â | 0.18 | Â | 0.1 | Â | 0.89 |
Normal | 432 | 64.22(24.24) | Â | 66.24(26.13) | Â | 53.74(28.31) | Â | 59.61(27.08) | Â | 62.99(22.19) | Â |
Abnormal | 16 | 62.85(20.76) | Â | 64.79(25.38) | Â | 56.77(28.78) | Â | 61.81(26.44) | Â | 68.30(18.70) | Â |
Dyslipidemia | Â | Â | 12.61*** | Â | 0.92 | Â | 1.51 | Â | 0.34 | Â | 2.92 |
No | 71 | 75.27(17.08) | Â | 73.99(25.87) | Â | 58.69(29.48) | Â | 63.61(27.10) | Â | 70.59(18.26) | Â |
Yes | 264 | 66.41(23.64) | Â | 70.63(26.23) | Â | 53.93(28.76) | Â | 61.49(27.17) | Â | 65.95(20.85) | Â |